Company Overview and News

11
Dividend Sensei's Portfolio Update 55: Why I Love Stock Market Corrections

2018-10-16 seekingalpha - 2
Unlike most investors, who fear sharply falling prices, I become most excited when the market runs deep red.
TXN UNIT AQN SHLD IRM BLK NBLX BRX OHI KIM

 
AQN / Algonquin Power & Utilities Corp SUPPL

2018-10-15 sec.gov
TABLE OF CONTENTS
AQN

 
The Zacks Analyst Blog Highlights: Ameren, Pattern Energy, Algonquin, Sysco and Anthem

2018-10-12 zacks
Chicago, IL –October 12, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ameren Corp. (AEE - Free Report) , Pattern Energy Group Inc. (PEGI - Free Report) , Algonquin Power & Utilities Corp. (AQN - Free Report) , Sysco Corp.
SYY AEE PEGI STLD PEG ANTM LB OUT AQN

 
5 Ultra-Safe Stocks That Will Endure the Wall Street Bloodbath

2018-10-12 investorplace
The stock market freefall continues in October, as investors remain worried about interest rates rising from historic low levels. The recent rise in benchmark bond yield has marred the appeal of stocks, especially with valuations near historically high levels.
SYY AEE PEGI PEG ANTM AQN

 
AQN / Algonquin Power & Utilities Corp 6-K COVER FOR Q3 (Current Report of Foreign Issuer)

2018-10-11 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
AQN

 
5 Ultra-Safe Stocks to Survive the Wall Street Bloodbath

2018-10-11 zacks
The stock market freefall continues in October, as investors remain worried about interest rates rising from historic low levels. The recent rise in benchmark bond yield has marred the appeal of stocks, especially with valuations near historically high levels.
SYY AEE PEGI PEG ANTM AQN

1
AQN / Algonquin Power & Utilities Corp 6-K COVER FOR PRESS RELEASE (Current Report of Foreign Issuer)

2018-10-11 sec.gov - 1
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
AQN

 
AQN / Algonquin Power & Utilities Corp FWP

2018-10-10 sec.gov
FREE WRITING PROSPECTUS Filed Pursuant to Rule 433 Registration No. 333-227245
AQN

2
Why Should You Invest in FirstEnergy Before Q3 Earnings?

2018-10-10 zacks
Earnings estimates for FirstEnergy Corporation (FE - Free Report) have been revised upward in the past 90 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings inched up 2.0% and 2.4% to $2.46 and $2.52, respectively. Shares of FirstEnergy have gained 20.4% in the past 12 months, against the industry’s decline of 3.6%.
AEE YUM FE AQN

6
Frontier Communications (FTR) to Launch New Gigabit Service

2018-10-10 zacks
In order to augment its Fiber broadband services in regional emerging markets, Frontier Communications Corporation (FTR - Free Report) recently announced that it is bringing a new Gigabit service in its FiOS and Vantage Fiber markets. The company aims to offer its fastest residential broadband service, increasing new consumer broadband service to 200/200 megabits per second (Mbps) as well as add higher speeds in Indiana, Oregon and Washington with 300/300 Mbps.
FTRPR BKHU BKH FTR AQN

 
AQN / Algonquin Power & Utilities Corp SUPPL

2018-10-10 sec.gov
TABLE OF CONTENTS
AQN

6
4 Top Stocks to Hedge Your Portfolio Against Rising Rates

2018-10-09 zacks
The recent rise in benchmark bond yield has dampened enthusiasm for equities as it offers higher risk-free returns to investors. This has resulted in the broader equity market’s closing in the red for the last couple of trading sessions.
OLLI JBK GSC TFG GSJ CHEF AQN GS AEE GLSSP GJS

 
AQN / Algonquin Power & Utilities Corp SUPPL

2018-10-01 sec.gov
TABLE OF CONTENTS
AQN

12
Duke Energy Unit Submits Proposal to Lower Customer Bill

2018-09-24 zacks
Duke Energy Corp.’s (DUK - Free Report) subsidiary, Duke Energy Indiana, recently submitted a proposal to the Indiana Utility Regulatory Commission to lower electricity rates for customers. The filing is related to the company's Edwardsport coal gasification power plant. Notably, Duke Energy Indiana entered into an agreement with state regulators for the aforementioned filling and joint submission of the same.
DUKH AEE KBH DTW DTV DUK DTJ DTY AQN

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...